Dissecting the mechanistic basis for the increase in PGE2 synthesis in cancer cells during cytotoxic therapy, in contrast to previous reports32,33,40, we found the rise in PGE2 synthesis preceded caspase-3 proteolytic activity. Here, CASP3 is linked to cancer.